Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.
about
Glycemic control and hypoglycemia: is the loser the winner?Insulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical ExperienceContinuous subcutaneous insulin infusion in adult type 1 diabetes mellitus: data from a registry at the University Medical Centre Ljubljana, Slovenia.Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trialDiabetes: glycaemic control in type 2.Diabetes self-care and the older adultContinuous glucose monitoring in non-insulin-using individuals with type 2 diabetes: acceptability, feasibility, and teaching opportunitiesPatient treatment satisfaction after switching to NovoMix® 30 (BIAsp 30) in the IMPROVE™ study: an analysis of the influence of prior and current treatment factors.Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.A 16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes suboptimally controlled with multiple daily injections.Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analoguesDo perceptions of insulin pump usability impact attitudes toward insulin pump therapy? A pilot study of individuals with type 1 and insulin-treated type 2 diabetes.Application of the Ontario Diabetes Economic Model (ODEM) to Determine the Cost-effectiveness and Budget Impact of Selected Type 2 Diabetes Interventions in Ontario.Do We Need Updated Guidelines on the Use of Insulin Pump Therapy in Type 2 Diabetes? A Review of National and International Practice Guidelines.Continuous subcutaneous insulin infusion in patients with type 2 diabetes: a cohort study to establish the relationship between glucose control and plasma oxidized low density lipoproteinNovel simple insulin delivery device reduces barriers to insulin therapy in type 2 diabetes: results from a pilot studyTreating the spectrum of type 2 diabetes: emphasis on insulin pump therapy.Quality of life and technology: impact on children and families with diabetesAutonomy of patients with type 2 diabetes with an insulin pump device: is it predictable?Insulin aspart: a review.Health-related quality of life and treatment satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) trialImpact of insulin pump on quality of life of diabetic patients.Short-term effects of continuous subcutaneous insulin infusion therapy in perioperative patients with diabetes mellitus.Overnight versus 24 hours of continuous subcutaneous insulin infusion as supplement to oral antidiabetic drugs in type 2 diabetesPatch-pump technology to manage type 2 diabetes mellitus: hurdles to market acceptance.Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.Insulin pump for type 2 diabetes: use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes.Using insulin pump therapy in poorly controlled type 2 diabetes.Hypoglycemia in insulin-treated diabetes: a case for increased vigilance.The economic and clinical benefits of adequate insulin initiation and intensification in people with type 2 diabetes mellitus.Management of diabetes mellitus: is the pump mightier than the pen?Multiple Daily Injections OR Insulin Pump Therapy: Choosing the Best Option for Your Patient-An Evidence-based Approach.A Systematic Review of Patients' Perspectives on the Subcutaneous Route of Medication Administration.Intensive insulin therapy combined with metformin is associated with reduction in both glucose variability and nocturnal hypoglycaemia in patients with type 2 diabetes.The role of insulin pump therapy for type 2 diabetes mellitus.Insulin pump use in type 2 diabetes.Evaluation of diabetic patients after three month use of continuous subcutaneous insulin infusion, dispensed by a protocolled form at outpatient reference clinic of Taguatinga Regional Hospital.Insulinization: A promising strategy for the treatment of type 2 diabetes mellitus.Insulin Pump Class: Back to the Basics of Pump Therapy.Aspects of insulin treatment.
P2860
Q24645071-CDE0A07B-98D2-42B4-99C1-CB9506064F5CQ28085428-973404B1-6AEE-4D41-98FE-8948F8193E92Q30564482-0F360C4E-399E-4E89-BD1E-586C4636CFF1Q31043511-BE5CAD94-25A5-4BB3-AB3B-E4881CFC7EF6Q33446693-52452A57-C121-46F2-8A34-5F9B796B87C4Q34017239-311E35DA-11B1-4303-820F-731465A31FB5Q34129614-BAA4304A-6425-4714-BC55-2C4619AC3D35Q34238821-55B63D4A-AEAB-4527-9CB9-371B834AB511Q34449270-65FA6519-8E1A-45D8-A00F-4994FE3BD94DQ35336944-35BD7950-9AA3-4C6E-BE10-61B82E8A40F1Q35647028-D5BBED30-79AB-47B8-8901-9FCDDC79920CQ35830400-1EA73A82-8BBA-428E-8863-B3DAA3138DA3Q36040075-E494F571-9E19-446C-BAC0-C7B41422DED5Q36130870-E6B98420-6601-4511-A979-12F9BF9487C8Q36158965-55B8F9BE-44F3-491D-8EF7-3A5A987D505DQ36159008-BDE3C48C-BCAB-4AB8-846B-84F3EE7CBFFAQ36378641-E25D2426-8DFD-41D1-8E7D-5B5EE7E78377Q36464623-F7D67DDC-E191-4C54-BAC4-D80BF7E9A463Q36608943-C0FD2C86-36B3-4246-A234-5B0598BE835CQ36609772-995DDF63-1DD1-4823-AC67-E68A836E37BAQ36837487-0FF6D8F3-8F3B-46EC-B542-4717FADC1818Q37015613-EA32ACA1-8053-4A98-B8FA-90C44F8D0228Q37403943-68D5A8AA-B8E1-4937-ADB6-DFE600F396BBQ37404011-0307A819-AC27-4EBB-A82D-EEAB8C3BEA95Q37404286-C86D3C16-50B7-4306-AB5A-88FDF8F82EA5Q37453111-5504D9FE-7AC8-445B-AF6B-938B1129DBA5Q37577120-D87D27E4-38A2-44E9-8870-054272DC3152Q37767088-FE6887B9-2404-4AE9-92F1-65979FD844F3Q37890785-89A5C2B4-4747-4E74-9CAB-CE06B738C0F5Q37915625-4790A0F0-9488-443C-947B-470EC1288DCEQ37988797-399C0084-BB54-4F70-9406-F95E85A22203Q38580509-4DFCF6AB-47AE-42B5-A40F-4B146C32FF14Q38705140-34B5F8ED-A7A7-4FFD-9E1B-504350758A26Q38727756-7135B8CD-CA9E-448F-97A0-7EF79E74EBDDQ38836724-A0443CB1-2DF9-4E2A-9F20-9DB14BE602CBQ39865848-257FB761-BE53-427B-98EC-0F15509625C9Q40995851-B13BC750-7D9A-4F50-B364-671750D59F32Q41860557-B88EEB5A-17C0-4455-AA45-0AAFC78166A5Q42411671-08242A03-47F4-4908-9801-90B31FB032BAQ42947774-33242ECD-52C3-4525-B401-4A76A3676BB8
P2860
Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Continuous subcutaneous insuli ...... parallel-group, 24-week study.
@en
Continuous subcutaneous insuli ...... parallel-group, 24-week study.
@nl
type
label
Continuous subcutaneous insuli ...... parallel-group, 24-week study.
@en
Continuous subcutaneous insuli ...... parallel-group, 24-week study.
@nl
prefLabel
Continuous subcutaneous insuli ...... parallel-group, 24-week study.
@en
Continuous subcutaneous insuli ...... parallel-group, 24-week study.
@nl
P2093
P1433
P1476
Continuous subcutaneous insuli ...... parallel-group, 24-week study.
@en
P2093
Bruce W Bode
Gregory E Peterson
Irl B Hirsch
Janet B McGill
Jennifer B Marks
Philip Raskin
Richard L Weinstein
Rickey R Reinhardt
Sunder R Mudaliar
P304
P356
10.2337/DIACARE.26.9.2598
P407
P577
2003-09-01T00:00:00Z